← Open Payments lookup

MICHELLE ZEBROWSKI: Open Payments

NPI 1679847651 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,793 in 80 payments from 13 companies in 2025. Trend: 2023 $1,259 · 2024 $2,188 · 2025 $1,793

Food & beverage: $1,781Education: $12
CompanyPaymentsAmount
Janssen Biotech, Inc.19$488
ABBVIE INC.20$376
Takeda Pharmaceuticals U.S.A., Inc.10$211
Ardelyx, Inc.9$188
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$136
Madrigal Pharmaceuticals3$84
Janssen Scientific Affairs, LLC1$67
Aimmune Therapeutics, Inc.3$65
Phathom Pharmaceuticals, Inc.3$59
Gilead Sciences, Inc.2$37

Products named: TREMFYA, ENTYVIO, IBSRELA, RINVOQ, XIFAXAN, SKYRIZI, LINZESS, REZDIFFRA.

Industry payments across GA — which companies pay providers there.